PMID: 29782777Aug 1, 2016Paper

ANTIAGGREGANT ACTIVITY OF A NEW TRICYCLIC BENZIMIDAZOLE DERIVATIVE

Eksperimental'naia i klinicheskaia farmakologiia
A F KucheryavenkoA A Spasov

Abstract

The antiaggregant activity of a new benzimidazole derivative - 2,3,4,5-tetrahydro[1,3]diazepino[1,2-α]benzimidazole (DAB-15) has been investigated in vitro in comparison to reference drugs acetylsalicylic acid (ASA) and ticlid (ticlopidine) on the models of ASA, collagen, and epinephrine induced platelet aggregation in rabbits. It was established that DAB-15 exhibited dose-dependent antiaggregant activity. On the model of ASA-induced platelet aggregation, the effect of ADB-15 exceeded that of ASA and was slightly lower than that of ticlid. On the models of collagen, and epinephrine induced platelet aggregation, DAB-15 was reliably more active than the both reference drugs.

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Related Papers

Bulletin of Experimental Biology and Medicine
A F KucheryavenkoV A Anisimova
Recenti progressi in medicina
A AndrianiM Fabiani
Archivos De Farmacología Y Toxicología
C VillaverdeC Navarro
Eksperimental'naia i klinicheskaia farmakologiia
A A SpasovV A Anisimova
© 2022 Meta ULC. All rights reserved